Jung Choi - Sep 1, 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
Officer Title: Chief Business and Strategy Officer
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Sep 1, 2022
Transactions value $
-$126,827
Form type
4
Date filed
9/6/2022, 07:00 PM
Previous filing
Aug 3, 2022
Next filing
Sep 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise +2.76K +1.4% 201K Sep 1, 2022 Direct F1
transaction GBT Common Stock Options Exercise +2.21K +1.1% 203K Sep 1, 2022 Direct F1
transaction GBT Common Stock Tax liability -$127K -1.86K -0.92% $68.15 201K Sep 1, 2022 Direct F2
holding GBT Common Stock 25K Sep 1, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -2.76K -16.67% $0.00 13.8K Sep 1, 2022 Common Stock 2.76K Direct F1, F3
transaction GBT Restricted Stock Units Options Exercise $0 -2.21K -12.5% $0.00 15.5K Sep 1, 2022 Common Stock 2.21K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 4,971 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F4 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2022, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Remarks:

Officer Title: Chief Business and Strategy Officer